The Dangerous Allure of Compounded GLP-1 Drugs
This image was generated by AI and may not depict real events.
Compounded GLP-1 medications, often used for weight loss, pose significant safety risks due to lack of regulation and potential contamination. A recent case of acute liver failure highlights the dangers of these unregulated medications, which can have inconsistent quality and effectiveness.
Compounded GLP-1 medications are being used to fill a gap in the market, but they can have significant safety issues. These medications are largely unregulated and may contain contaminated ingredients. A recent case involved a man who took a compounded injectable containing the active ingredient in Zepbound and suffered acute liver failure. Almost one in eight adults in the US reports having tried a GLP-1 medication, with many using them for weight loss. However, these medications can be costly, with a one-month supply of brand-name medications typically costing between $900 and $1,400. Compounded drugs use FDA-approved ingredients, but the customized medication itself is not FDA-approved, posing a risk to patient safety.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.